Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

By Rossi Carlo  

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3000-3007

Springer Publishing Company

Access to resources Recommend Favorite

Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: A pilot study in patients with in-transit metastases of malignant melanoma

By Olofsson Roger  

International Journal of Hyperthermia, Vol. 29, Iss. 3, 2013-05 ,pp. : 234-238

Informa Healthcare

Access to resources Recommend Favorite

TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial

By Rossi Carlo  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1218-1223

Springer Publishing Company

Access to resources Recommend Favorite

Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities

By Boesch Cedric E.   Meyer Thomas   Waschke Lena   Merkel Susanne   Goehl Jonas   Hohenberger Werner   Knorr Christian  

International Journal of Hyperthermia, Vol. 26, Iss. 1, 2010-06 ,pp. : 16-20

Informa Healthcare

Access to resources Recommend Favorite

Current status of hyperthermic limb perfusion for in-transit melanoma

By I. Ross Merrick  

International Journal of Hyperthermia, Vol. 24, Iss. 3, 2008-01 ,pp. : 205-217

Informa Healthcare

Access to resources Recommend Favorite